Please assess the completion status of the following clinical trial:

Trial Title: Onset of Effect of Mometasone Nasal Spray in Induced Allergic Rhinitis (Study P03431)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* at least 12 years old,~* had a history of SAR to ragweed pollen for at least one year~* had a positive skin test (prick) to short ragweed allergen.~* if female, had a negative urine pregnancy test (HCG) at the Screening Visit, and prior to treatment on the Treatment Visit~* were non pregnant women of childbearing potential and used a medically acceptable, adequate form of birth control.~Exclusion Criteria:~* developed signs or symptoms of bronchospasm, i.e., wheezing, dyspnea, and/or cough, during the priming sessions;~* had any significant medical condition which, in the judgment of the investigator, might interfere with the study or require treatment;~* had an upper respiratory or sinus infection within two weeks prior to treatment;~* had received escalating doses of immunotherapy, oral immunotherapy or short course (rush) immunotherapy for treatment of rhinitis;~* were female subjects who were pregnant, breast feeding, or premenarchal;~* could not adhere to concomitant medication prohibitions;~* had a known potential for hypersensitivity, allergy, or idiosyncratic reaction to mometasone furoate nasal spray;~* had asthma that requires systemic or inhaled corticosteroid treatment;~* had large nasal polyps, marked septum deviations, or any other nasal structural abnormality that significantly interferes with nasal airflow;~* had rhinitis medicamentosa;~* had any relevant abnormal vital sign due to an unknown underlying disease and considered by the investigator and Sponsor Monitor to contraindicate study participation.

- Gender: ALL
- Minimum Age: 12 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Mometasone Furoate Nasal Spray (Type: EXPERIMENTAL): None
- Placebo Nasal Spray (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).